Skip to main content
. 2022 Oct 7;13:1011333. doi: 10.3389/fphar.2022.1011333

FIGURE 7.

FIGURE 7

The underlying mechanism of Chuanzhitongluo capsule ameliorating microcirculatory dysfunction. AA, arachidonic acid; LTB4, leukotriene B4; LTB4R1, leukotriene B4 receptor type 1; ICAM-1, intercellular cell adhesion molecule-1; IL-6, interleukin-6; SGPL1, sphinganine-1-phosphate aldolase; S1P, sphingosine-1-phosphate; SphK, sphingosine by sphingosine kinases; S1P1, sphingosine-1-phosphate receptor type 1.